Complement Forum (online)
ECN Forum on Complement in Renal Diseases
11th December 2025 | 15:00 CET (09:00 EST)
We are pleased to announce the second ECN Online Symposium.
This time we will focus on the role of Complement in Renal Diseases, another field that complement biology has been at the forefront of both discovery science and translational research. We are entering a new era of use of complement-targeted therapeutics in renal diseases and we hope this symposia will give you update on that progress and define some of the challenges that remain.
We trust our 2nd symposium will continue to be an exciting platform for fostering discussions and collaboration among researchers and clinicians interested in the complement cascade.
Programme
aHUS: from genetics to treatments and now the undiscovered country
Prof. David Kavanagh
C3G/IC-MPGN –
do we have a
treatment?
Prof. Marina Noris
IgAN
in the era of
anti-complement drug.
Prof. Jon Barratt
Complement biomarkers
and therapies in
ANCA-associated vasculitis.
Sophia Lionaki
30-Minute Round Table Discussion
The Speakers and Chairs will discuss the latest progress, remaining challenges, and emerging directions in complement discovery research and therapeutic treatment in renal diseases. Members of the audience are encouraged to actively participate by asking questions.
Schedule Dec 11, 2025
15:00 CET: Welcome
15:05 CET: aHUS: from genetics to treatments and now the undiscovered country. - Prof. David Kavanagh
15:30 CET: C3G/IC-MPGN– do we have a treatment? - Prof. Marina Noris
15:55 CET: Short break
16:10 CET: IgAN in the era of anti-complement drug - Prof. Jon Barratt
16:35 CET: Complement biomarkers and therapies in ANCA-associated vasculitis - Assoc. Prof. Sophia Lionaki
17:00 CET: Round table discussion chaired by Elena Goicoechea de Jorge and Kevin Marchbank
17:25 CET: Closing remarks
Registration
For registration please fill out the form below. Upon registration, a confirmation email with the access details will be sent to you. Please note that the event will be recorded, but access to the recording will be limited to ECN members for up to two weeks following the event.